131 related articles for article (PubMed ID: 38621888)
1. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for economic evaluation of post-marketing Chinese patent medicine].
Shi LW; Xie YM; Nie XY; Han S; Tian X; Wang ZF
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1129-1136. PubMed ID: 38621920
[TBL] [Abstract][Full Text] [Related]
3. [Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].
Xu BW; Wu JY; Li J; Zhang Y; Cao LC; Zhang XX; Gao RK
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1980-1987. PubMed ID: 33982508
[TBL] [Abstract][Full Text] [Related]
4. [Evidence map analysis of randomized controlled trial of commonly used Chinese patent medicines in treatment of type 2 diabetes mellitus in recent five years].
Jiang JJ; Jing YY; Li YY; Yang YN; Liao X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1102-1112. PubMed ID: 38621917
[TBL] [Abstract][Full Text] [Related]
5. [Thoughts on post-marketing evaluation of classical Chinese patent medicines based on clinical value].
Song Z; Wang ZF; Wu Y; Xie YM; Yang YF; Xu Y
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1988-1993. PubMed ID: 33982509
[TBL] [Abstract][Full Text] [Related]
6. [Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes].
Ma LX; Wang YY; Li XX; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2012 Mar; 10(3):279-92. PubMed ID: 22409917
[TBL] [Abstract][Full Text] [Related]
7. [Expert consensus on core indicators for lifecycle value assessment of Chinese patent medicine].
Yu YN; Liu J; Li B; Dang HX
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5389-5396. PubMed ID: 38114128
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trials and evaluation of Chinese patent medicine for chronic obstructive pulmonary disease].
Feng CN; Hu HY; Ji ZC; Qiang XY; Chen Z; Ou Y; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2351-2357. PubMed ID: 35531683
[TBL] [Abstract][Full Text] [Related]
9. [Report standards for clinical comprehensive evaluation of Chinese patent medicine].
Zhang Q; Wang ZF; Xie YM; Li YY; Wang LX; Liu H; Geng HJ; Cui X; Liu FM; Sun CQ; Wei RL; Zhang LD
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6062-6067. PubMed ID: 34951233
[TBL] [Abstract][Full Text] [Related]
10. [Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine].
Xie YM; Liao X; Jiang JJ; Zhang YL; Ma R; Zhu MJ; Zhan SY; Liu JP; Liu J; Wen ZH; Yang ZQ; He Y; Li XL
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2896-2901. PubMed ID: 31602831
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trials and evaluation of Chinese patent medicine for influenza].
Sheng XD; Chen Z; Ji ZC; Hu HY; Ou Y; Cao LJ; Guo LP; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2338-2342. PubMed ID: 35531681
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trials and evaluation of Chinese patent medicine for stroke].
Feng CN; Ji ZC; Peng DH; Hu HY; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2330-2337. PubMed ID: 35531680
[TBL] [Abstract][Full Text] [Related]
13. [Evidence map of clinical research on Chinese patent medicines for post-acute myocardial infarction heart failure].
Zhang CD; Huang JY; Wang YX; Zhu MJ; Xing ZY; Qiu BY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1673-1682. PubMed ID: 38621951
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trials and evaluation of Chinese patent medicine for pneumonia].
Ji ZC; Qiang XY; Hu HY; Chen Z; Ou Y; Feng CN; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2343-2350. PubMed ID: 35531682
[TBL] [Abstract][Full Text] [Related]
15. [Application of objective performance criteria in post-marketing evaluation schemes of traditional Chinese medicine].
Zhang C; Yu MK; Tang JP; Huo YQ; Fei YT; Wang ZF; Xu Q; Xie YM
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1999-2003. PubMed ID: 33982511
[TBL] [Abstract][Full Text] [Related]
16. [Analysis and reflection on current situation of Chinese patent medicine for children in China].
Liu H; Chen YJ; Fu QF; Zhao SY; Nie LH; Ma R; Rong P
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1966-1973. PubMed ID: 38812209
[TBL] [Abstract][Full Text] [Related]
17. [Technical specification for re-evaluation of post-marketing clinical effectiveness of traditional Chinese medicine (first draft)].
Zhao Y; Yang YY; Wang YX; Yang HM; Wu SX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3211-3215. PubMed ID: 30200720
[TBL] [Abstract][Full Text] [Related]
18. [Evidence mapping of clinical research on 28 Chinese patent medicines for tension-type headache].
Guan YY; Yu XY; Li CY; Shu JZ; Tao WQ; Mi XJ; Luo XQ; Lian ZY; Zhao YH; Tang J; Liao X
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6558-6567. PubMed ID: 34994149
[TBL] [Abstract][Full Text] [Related]
19. [Clinical trials and evaluation of Chinese patent medicine for heart failure].
Wu XL; Qiang XY; Ji ZC; Hu HY; Feng CN; Wang DL; Peng DH; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2322-2329. PubMed ID: 35531679
[TBL] [Abstract][Full Text] [Related]
20. [Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].
Yang ZQ; Tang HM; Tang YQ; DU YP; Yuan WA; Li B; Zou C; Tang JY; Gao R; Hu SY; Zhang L
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1686-1690. PubMed ID: 33982469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
